tiprankstipranks
PCI Biotech Holding ASA (DE:4QG)
FRANKFURT:4QG
Holding DE:4QG?
Track your performance easily

PCI Biotech Holding ASA (4QG) Financial Statements

1 Followers

PCI Biotech Holding ASA Financial Overview

PCI Biotech Holding ASA's market cap is currently ―. The company's EPS TTM is €-0.779; its P/E ratio is -0.15; PCI Biotech Holding ASA is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenuekr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit-----
EBITkr -10.61Mkr -14.43Mkr -22.42Mkr -28.04Mkr -21.21M
EBITDAkr -10.45Mkr -14.28Mkr -16.49Mkr -27.39Mkr -20.58M
Net Income Common Stockholderskr -10.70Mkr -14.69Mkr -23.01Mkr -25.05Mkr -21.42M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 67.22Mkr 76.33Mkr 93.68Mkr 115.18Mkr 135.51M
Total Assetskr 73.94Mkr 93.25Mkr 109.41Mkr 135.98Mkr 154.68M
Total Debtkr 1.43Mkr 1.59Mkr 1.75Mkr 1.91Mkr 2.01M
Net Debtkr -65.79Mkr -74.74Mkr -91.93Mkr -113.27Mkr -133.50M
Total Liabilitieskr 10.45Mkr 17.32Mkr 20.61Mkr 22.19Mkr 18.55M
Stockholders Equitykr 63.48Mkr 75.93Mkr 88.80Mkr 113.79Mkr 136.14M
Cash Flow-
Free Cash Flowkr -8.84Mkr -18.17Mkr -21.59Mkr -17.32Mkr -13.14M
Operating Cash Flowkr -8.84Mkr -18.17Mkr -21.59Mkr -17.32Mkr -13.14M
Investing Cash Flowkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Financing Cash Flowkr -176.00Kkr -175.00Kkr -175.00Kkr -337.00Kkr -168.00K
Currency in NOK

PCI Biotech Holding ASA Earnings and Revenue History

PCI Biotech Holding ASA Debt to Assets

PCI Biotech Holding ASA Cash Flow

PCI Biotech Holding ASA Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis